A toxicity study of different polyamidoamine (PAMAM) dendrimers in Swiss albino mice was performed with a clinical overview. In the current study, mice were treated with various G4 dendrimers (NH 2 and OH surface groups) at different dosage levels (low, medium and high) via the intraperitoneal route for 15 consecutive days, followed by a 15 day recovery period. The toxicity profile was investigated in mice for their general behaviour, feed intake, body weight, carbohydrate, lipid and protein metabolism, haematological parameters, histopathology and cell viability. No significant differences were observed in feed intake, body weight and organ weight among the various dendrimer-fed groups and control. In general, dendrimers have no significant effect on the carbohydrate and lipid metabolism. However, declined glucose levels in the high-NH 2 dose group indicates the interference of this dosage level with glucose metabolism. Although all the test groups showed activity in the normal range, the high-NH 2 group showed comparatively higher alanine aminotransferase and aspartate aminotransferase activity. Minor, but insignificant (p > 0.05), differences were observed in the red blood cells, haematocrit value and haemoglobin of the treated group when compared to the control group in a dose-dependent manner, but these recovered during the recovery period. There was no effect on other haematological parameters. Histopathological evaluation of dendrimer-treated groups did not reveal any abnormalities in the low-and medium-dose groups, but at a high dose level, toxicity was observed in the liver and kidney. However, after the recovery period, toxicity in the high dose level was not found. A cell viability study of cationic dendrimers has shown reduced cytotoxicity after the complexation with a guest molecule such as indomethacin. This study showed that dendrimers are not toxic, in general. The high dose of G4-NH 2 displayed some toxicity; however, that too was recovered after some time.
Introduction
Polyamidoamine (PAMAM) dendrimer is one of the most investigated molecules in the recent past (figure 1). Synthesis of various PAMAM dendrimers has been described in detail by Esfand & Tomalia (2001a,b) . High surface density and empty inner spaces provide a flexible option for diverse application of dendrimers in drug/gene delivery (Tomalia et al. 1990 ; Khopade et al. 1999 Khopade et al. , 2002 Kono et al. 1999; Zhuo et al. 1999; Kojima et al. 2000; Esfand & Tomalia 2001a,b; Chauhan et al. 2003 Chauhan et al. , 2004 Chauhan et al. , 2009 Asthana et al. 2005; Svenson & Chauhan 2008) . Moreover, there are some reports of dendrimers with inherent therapeutic properties (Chauhan et al. 2009; Mumper et al. 2009 ). These bioactive dendrimers open a new avenue in dendrimer research.
Transformation of dendrimers from a bioactive to a pharmaceutically acceptable drug depends upon the toxicity profile. The toxicity profile of PAMAM dendrimers was studied for their cytotoxic and haemolytic parameters with specific objectives (Roberts et al. 1996; Malik et al. 2000; Fischer et al. 2003; Domanski et al. 2004) . Jevprasesphant et al. (2003) reported decreased cytotoxicity through modifying dendrimer surfaces via attachment of six laouroyl or four poly(ethylene glycol) (PEG) chains. Similar studies by Chen et al. (2004) using melamine-based dendrimers suggested that the surface modification of these macromolecules has profound effects on haemolysis and cytotoxicity, where anionic and PEGylated dendrimers have a biocompatible nature. However, Duncan (2003) reported that anionic polymers bear anticoagulant activity and can stimulate cytokine release.
PAMAM G4 dendrimers are widely used, in drug delivery and biomedical applications, among the various generations available, and hence are selected for the present study. We demonstrate the general sub-acute toxicity of different PAMAM dendrimers in mice with a preclinical overview. We investigate the toxicity profile of G4 dendrimers bearing -NH 2 and -OH surface functionality for general behaviour, feed intake, body weight, carbohydrate, lipid and protein metabolism, haematological parameters, histopathology and in vitro cell viability. The effect of dose was also studied with PAMAM G4-NH 2 dendrimers. 
Material and methods

(a) Setup of animal house
Swiss albino mice, 6-8 weeks of age, weighing between 20 and 25 g, were procured from the National Institute of Nutrition, Hyderabad, India. The mice were kept at 22 ± 2 • C and 50-70% relative humidity and were maintained in a 12 : 12 h light : dark cycle. The commercial basic diet (in a measured quantity) and water were provided ad libitum. Following a 10 day acclimatization period, mice were randomly assigned to five groups, with each group consisting of 12 mice. Investigations using experimental animals adhered to the 'principles of laboratory animal care' (National Institute of Health Publication No. 85-23, revised in 1985) .
(b) Sub-acute toxicity study Two different types of dendrimers (Aldrich Chemicals, USA) at different dosage levels (table 1) were administered using the intraperitoneal (i.p.) route for 15 days, followed by a 15 day recovery period without any further dosing. Food and body weight were recorded regularly during the study. All mice were observed daily for general behaviour and toxicological signs and symptoms. On the 15th day, the remaining animals were decapitated after the recovery period. In some cases, serum of the same group was pooled and analysed.
(c) Haematological examination
Blood was collected from the tail vein of mice using ethylenediaminetetraacetic acid (EDTA) as an anticoagulant. Red blood cells (RBCs), white blood cells (WBCs), haematocrit (HCT), haemoglobin, etc. were measured by an automatic blood cell counter (Medonic 620, USA).
(d) Serum biochemical examination
Blood was collected from the tail vein of the mice without using any anticoagulant. Serum was separated by centrifugation and maintained at −20
• C until further use. Serum analysis of glucose, cholesterol, triglycerides, total protein, albumin, creatinine, urea nitrogen, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were performed using a RA-1000 auto analyser (Bayer Diagnostics, Ireland).
(e) Autopsy and histology
All organs were observed macroscopically for gross examination of anatomical localization and pathological changes. Selected organs, such as the liver, lung, kidney, spleen, heart, stomach, thymus, adrenal and lymph nodes, were excised, blotted and weighed.
Tissues were fixed in 10 per cent buffered neutral formalin. These were embedded in paraffin and sectioned and stained with haematoxylin and eosin for histopathological examination.
(f ) Cell viability
Cell viability was measured using the trypan blue exclusion test, which was based on the ability of trypan blue to stain dead cells. The number of viable and non-viable cells was counted by using a haemocytometer. Percentage cytotoxicity is calculated as per cent cytotoxicity = (total number of viable cells) − (total number of viable cells after treatment) total number of viable cells .
Cell suspensions (100 μl) of Chinese hamster ovary (CHO) and human fibroblast (FIII) cell lines (procured from CCMB, Hyderabad, India) were seeded in 96 well plates at a concentration of 2.5 × 10 6 cells ml −1 . Cells were incubated with various dendrimers at different concentrations (0.0001, 0.01, 1, 100 and 200 μg ml −1 ) in a humidified 5 per cent CO 2 incubator at 37
• C for 18 h. Supernatants were removed, trypan blue was added to the cells and absorbance at 595 nm was determined using a microplate reader to determine the per cent cytotoxicity.
Results and discussion
Mice were treated with various dendrimers at different dosage levels via the i.p. route for 15 consecutive days followed by a 15 day recovery period. Body weight is generally employed as an indicator of adverse effects after exposure to toxic chemicals. Reduction in body weight, along with feed intake, are simple and sensitive parameters of toxicity, in general. Feed intake did not show any changes among the various groups, but the high-NH 2 dose group showed different patterns from various groups, including the control (figure 2). Control, low-NH 2 , medium-NH 2 and medium-OH groups have followed somewhat similar patterns for feed intake. In the recovery period, medium-NH 2 and medium-OH groups have shown increased food consumption. Initially, the high-NH 2 dose group has less percentage of feed consumption, but it increased significantly after the eighth day, which may be due to more demand from the body for the available source of energy. But, this sudden increase in food intake could not be transformed into an increase in the body weight; on the contrary, body weight decreased in the recovery period and two mice died on day 26 (figure 3).
There was no significant difference observed in the body weight between the various groups initially (15 days, p > 0.05), but during the recovery period, weight gain was observed in the medium-NH 2 and medium-OH groups in comparison to control and low-NH 2 groups (p < 0.05). The mean organ weight was similar in all the groups, and did not show any gross alteration in the absolute weight of the various organs (tables 2 and 3).
The observed changes in carbohydrate, lipid and protein metabolism are difficult to interpret since many factors affect each other in a complex way. The glucose level was found to be low in the high-NH 2 dose group, which indicates 82 ± 7.9 75 ± 7.2 79 ± 6.9 medium-NH 2 88 ± 6.6 75 ± 7.5 90 ± 7.8 high-NH 2 98 ± 7.1 81 ± 7.5 81 ± 6.5 a medium-OH 94 ± 9.1 81 ± 11.5 91 ± 7.1 a n = 4. control 95 ± 8.9 93 ± 9.8 92 ± 9.1 low-NH 2 100 ± 9.1 85 ± 8.9 89 ± 6.8 medium-NH 2 99 ± 10.8 81 ± 10.5 85 ± 7.5 high-NH 2 108 ± 11.5 85 ± 7.8 81 ± 7.5 a medium-OH 95 ± 6.9 82 ± 8.6 91 ± 8.1 a n = 4.
in the high-NH 2 dosage group. Overall, we did not find any significant effect of dendrimers on the carbohydrate and lipid metabolism, as observed from the concentrations that fall in the normal range in all the groups of mice (tables 4-6). Clinical biochemistry is used as a tool to assess the cellular alteration that affects the extracellular concentration of enzymes and non-enzymatic substrates produced within the cells. Enzymes were categorized into two groups: (i) production enzymes and (ii) leakage enzymes. Some other factors, such as molecular weight, intracellular positioning, concentration gradient, pathway of enzymatic catabolism and organ specificity, are also important while assessing the enzymatic data (Everett & Harrison 1983) . Although all the test groups showed activity in the normal range, the high-NH 2 group has shown comparatively higher ALT and AST activity in serum than the control group (tables 7 and 8). Both AST and ALT are leakage enzymes and are found mainly in liver (Papadimitriou & VanDuijn 1970) . Generally, these enzymes are not present in serum of mice in normal conditions and are only found in serum following hepatic injury (Fassati et al. 1969) . Hence, a small increase in the serum AST and ALT levels indicates the adverse effect of the high-NH 2 dose group on the liver. Liver synthesizes serum proteins, except for immunoglobulins. Hypoproteinaemia is evident only in the case of severe hepatic dysfunction. No significant difference has been observed regarding the effect on total protein and albumin in serum control 90 ± 10.5 91 ± 9.9 85 ± 8.1 low-NH 2 85 ± 7.9 91 ± 9.5 70 ± 6.5 medium-NH 2 84 ± 7.8 90 ± 8.9 70 ± 7.1 high-NH 2 98 ± 10.2 120 ± 13.5 82 ± 8.5 a medium-OH 83 ± 6.8 87 ± 9.5 70 ± 5.9 a n = 4. control 35 ± 2.6 37 ± 1.6 36 ± 1.5 low-NH 2 32 ± 3.6 34 ± 1.6 29 ± 0.9 medium-NH 2 32 ± 2.7 34 ± 1.9 30 ± 2.1 high-NH 2 35 ± 5.1 49 ± 2.5 32 ± 1.8 a medium-OH 32 ± 3.9 39 ± 1.6 31 ± 1.5 a n = 4. Table 9 . Effect of various dendrimers on plasma total protein concentration (g dl −1 ) after i.p. administration in Swiss albino mice (n = 6).
control 3.1 ± 0.1 3.5 ± 0.7 3.5 ± 0.6 low-NH 2 4.2 ± 0.3 4.3 ± 0.6 3.2 ± 0.5 medium-NH 2 3.9 ± 0.5 4.4 ± 0.4 3.2 ± 0.4 high-NH 2 4.2 ± 0.4 3.5 ± 0.6 3.1 ± 0.6 a medium-OH 4.5 ± 0.45 4.2 ± 0.5 3.4 ± 0.3 a n = 4.
between the control and other dosage levels (tables 9 and 10). These, along with the ALT and AST parameters, suggest that the dendrimer does not possess severe toxicity to the liver, except to some extent in high-NH 2 dose levels, and that too was recovered during the recovery period. Kidney excretes excess nitrogen as urea, and this provides a simple means to assess renal functioning. Creatinine is not metabolically active and is largely excreted in urine. Creatinine levels provide the most accurate information about Table 10 . Effect of various dendrimers on plasma albumin concentration (g dl −1 ) after i.p. administration in Swiss albino mice (n = 6). day formulations 0 (g dl −1 ) 1 5 ( g d l −1 ) 3 0 ( g d l −1 ) control 1.8 ± 0.1 2.4 ± 0.3 1.6 ± 0.5 low-NH 2 1.6 ± 0.5 2.2 ± 0.4 1.5 ± 0.6 medium-NH 2 2.2 ± 0.4 2.6 ± 0.4 1.5 ± 0.3 high-NH 2 1.9 ± 0.4 2.3 ± 0.5 1.2 ± 0.3 a medium-OH 2.3 ± 0.4 2.5 ± 0.3 1.3 ± 0.2 a n = 4. control 0.4 ± 0.09 0.5 ± 0.10 0.6 ± 0.12 low-NH 2 0.5 ± 0.08 0.5 ± 0.09 0.7 ± 0.15 medium-NH 2 0.5 ± 0.10 0.6 ± 0.10 0.5 ± 0.14 high-NH 2 0.6 ± 0.05 0.4 ± 0.12 0.5 ± 0.15 a medium-OH 0.4 ± 0.09 0.5 ± 0.10 0.6 ± 0.13 a n = 4. renal function (Walker 1984) . Unless severe injury or kidney damage occurs, blood urea nitrogen and creatinine do not increase as the kidney has a large functional reserve capacity. Dendrimers have not shown any effect on the levels of blood urea nitrogen and creatinine, and hence biochemical evaluation does not indicate any detrimental effect of dendrimers on the kidney (tables 11 and 12).
Minor, but insignificant (p > 0.05), differences were observed in the RBCs, HCT value and haemoglobin of the treated groups when compared to the control group in a dose-dependent manner, but these recovered during the recovery period (table 13) . The high-NH 2 dosage group showed a more pronounced effect. No significant variation was found in other haematological examinations between the control and test groups.
Autopsy of the liver, lung, kidney, spleen, heart, stomach, lymph nodes, thymus and adrenal did not reveal any major abnormalities in any of the groups of mice. The liver showed focal infiltrates of lymphocytes and plasma cells, patchy congestion, foci of hepatocytic necrosis and Kupfer cell hyperplasia only at high-NH 2 dose levels, which was found to be partially recovered after the recovery period (tables 14 and 15). There were no significant changes in the low-NH 2 , medium-NH 2 and medium-OH dose groups. The kidney showed local inflammation and tubular atropy of unknown significance at high-NH 2 dose levels, and they were not persistent. No changes were observed in any of the other above-mentioned organs.
The toxicity of a molecule largely depends upon its surface, and hence dendrimer toxicity may be affected after drug complexation. Dendrimers are widely used as drug-delivery systems, so it is important to distinguish between the toxicity of dendrimers alone and the dendrimer-drug complex. Cell viability was tested on CHO and FIII cell lines (figures 4 and 5). The NH 2 -and OH-containing dendrimers showed significant toxicity towards these cell lines. No toxicity was observed until 1 μg ml −1 concentration, but at 100 μg ml −1 , approximately 80 per cent, and at 200 μg ml −1 , approximately 90 per cent cytotoxicity was observed in both the cationic dendrimers. Anionic dendrimers did not show any toxicity, even up to 200 μg ml −1 (data not shown). These findings corroborate well with the results of Malik et al. (2000) . These results suggest that the cationic nature of the dendrimer is mainly responsible for the toxicity, as the anionic dendrimer does not show any toxic effect. The per cent cytotoxicity of different dendrimers was compared with their respective indomethacin complexes. The G4-NH 2 -indomethacin complex showed significantly less cytotoxicity than the dendrimer of the same concentration in both the cell lines (at 100 μg ml −1 , 75% versus 59% for CHO and 78% versus 65% for FIII cell lines). A similar pattern was seen for the G4-OH-indomethacin complex when compared to the G4-OH dendrimer (at 100 μg ml −1 , 77% versus 61% for CHO and 79% versus 67% for FIII cell lines). The complexes of cationic dendrimers and indomethacin were formulated for the controlled delivery of indomethacin. The -COOH group of indomethacin was attached to -NH 2 /-OH groups of dendrimers through electrostatic interaction or hydrogen bonding. Thus, the cationic magnitude of dendrimers was reduced considerably after complexation with indomethacin, and hence the cytotoxicity. This reduction of cationic potential was further confirmed by zeta potential measurements (data not shown).
Conclusions
A PAMAM dendrimer toxicity profile was created by investigating effect of dendrimers on feed intake, body weight, glucose, lipid and protein metabolism, kidney and liver functions, blood profile, organ weight and organ toxicity (by Table 13 . Haematological profiles of Swiss albino mice treated with various dendrimers at different dose levels after i.p. administration (n = 6). RBC, red blood cell count; MCV, mean corpuscular volume; RDW%, red cell distribution width percentage; RDWA, red blood cell distribution width, absolute; HCT, haematocrit; PLT, platelet count; MPV, mean platelet volume; PDW, platelet distribution width; PCT, platelet crit; LPCR, large platelet concentration ratio; WBC, white blood cell count; HGB, haemoglobin; MCH, mean corpuscular haemoglobin; MCHC, mean corpuscular haemoglobin concentration. Table 15 . Sub-acute toxicity study of dendrimers in mice (terminated on 30th day)-histopathology report.
group/sex, F control low-NH 2 medium-NH 2 high-NH 2 medium-OH organ pathology (n = 6) (n = 6) (n = 6) (n = 4) (n = 6) histopathology). A toxicity study also elaborated on dendrimer surface chemistry and different dosage levels. PAMAM dendrimers are not toxic in general; however, high dosage of G4-NH 2 showed some toxicity, which was recovered after the recovery period. Dendrimer toxicity is mainly a function of its outer surface layer, and can be controlled judiciously by pacifying the surface layer. Furthermore, complexation of a guest molecule with dendrimers in a formulation reduces toxicity of the dendrimers. PAMAM dendrimers can be used safely by proper selection of concentrations, surface groups and additives.
